Search research articles
Contact Us
Filters
Showing results (781-790 of 831) with videos related to
Page
of 84
Sort By:
Neuro-Oncology
|
October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Cell Death & Disease
|
September 29, 2021
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma
Ulvi Ahmadov, Daniel Picard, Jasmin Bartl, et al.
Neuro-Oncology
|
July 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation
Florien W Boele, Sé M Frances, Amélie Darlix, et al.
Neuropathology and Applied Neurobiology
|
August 17, 2022
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types
Annekathrin Reinhardt, Kristin Pfister, Daniel Schrimpf, et al.
Nature Communications
|
February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics
Julia Velz, Lena K Freudenmann, Gioele Medici, et al.
Neuro-Oncology
|
October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
Acta Neuropathologica
|
April 16, 2026
Consensus statement on microglial and macrophage functions in gliomas
Yuqi Zheng, Islam Alzoubi, Manuel B Graeber, et al.
Neuro-Oncology
|
January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
Emilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
The Lancet. Oncology
|
August 29, 2014
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp, Monika E Hegi, Thierry Gorlia, et al.
Nature Cancer
|
August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Page
of 84
Search research articles
Search
Showing results (781-790 of 831) with videos related to
Sort By:
Page
of 84
Neuro-Oncology
|
October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Cell Death & Disease
|
September 29, 2021
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma
Ulvi Ahmadov, Daniel Picard, Jasmin Bartl, et al.
Neuro-Oncology
|
July 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation
Florien W Boele, Sé M Frances, Amélie Darlix, et al.
Neuropathology and Applied Neurobiology
|
August 17, 2022
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types
Annekathrin Reinhardt, Kristin Pfister, Daniel Schrimpf, et al.
Nature Communications
|
February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics
Julia Velz, Lena K Freudenmann, Gioele Medici, et al.
Neuro-Oncology
|
October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
Acta Neuropathologica
|
April 16, 2026
Consensus statement on microglial and macrophage functions in gliomas
Yuqi Zheng, Islam Alzoubi, Manuel B Graeber, et al.
Neuro-Oncology
|
January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
Emilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
The Lancet. Oncology
|
August 29, 2014
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp, Monika E Hegi, Thierry Gorlia, et al.
Nature Cancer
|
August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Page
of 84